Showing results (271-280 of 928) with videos related to
Sort By:
Pageof 93
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|May 31, 2022
Do Side Effects to the Primary COVID-19 Vaccine Reduce Intentions for a COVID-19 Vaccine Booster?Andrew L Geers, Kelly S Clemens, Ben Colagiuri, et al.International Clinical Psychopharmacology|July 26, 2018
Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trialMaurizio Fava, Suresh Durgam, Willie Earley, et al.Psychotherapy and Psychosomatics|July 5, 2002
Treatment approaches to major depressive disorder relapse. Part 1: dose increaseMark E Schmidt, Maurizio Fava, Shuyu Zhang, et al.Archives of General Psychiatry|June 7, 2006
The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey ReplicationRonald C Kessler, Emil F Coccaro, Maurizio Fava, et al.Neuroscience Letters|April 2, 2016
Antidepressant-like effect of low dose ketamine and scopolamine co-treatment in miceTracey L Petryshen, Michael C Lewis, Kelly A Dennehy, et al.Journal of Affective Disorders|September 3, 2020
Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart reviewHitoshi Sakurai, Felipe Jain, Simmie Foster, et al.Current Therapeutic Research, Clinical and Experimental|March 29, 2014
Clinical consequences of initial duloxetine dosing strategies: Comparison of 30 and 60 mg QD starting dosesDavid L Dunner, Madelaine M Wohlreich, Craig H Mallinckrodt, et al.The Journal of Clinical Psychiatry|August 16, 2023
Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled StudyRobert Riesenberg, Paul P Yeung, Ludmyla Rekeda, et al.Statistics in Medicine|February 20, 2022
Assessing treatment benefit in the presence of placebo response using the sequential parallel comparison designXiaoyan Liu, Chanmin Kim, Zifei Han, et al.Psychotherapy and Psychosomatics|July 5, 2002
Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatmentMaurizio Fava, Mark E Schmidt, Shuyu Zhang, et al.Pageof 93